Spinal Cord Stimulation Alleviates Motor Deficits in a Primate Model of Parkinson Disease

Although deep brain electrical stimulation can alleviate the motor symptoms of Parkinson disease (PD), just a small fraction of patients with PD can take advantage of this procedure due to its invasive nature. A significantly less invasive method--epidural spinal cord stimulation (SCS)--has been suggested as an alternative approach for symptomatic treatment of PD. However, the mechanisms underlying motor improvements through SCS are unknown. Here, we show that SCS reproducibly alleviates motor deficits in a primate model of PD. Simultaneous neuronal recordings from multiple structures of the cortico-basal ganglia-thalamic loop in parkinsonian monkeys revealed abnormal highly synchronized neuronal activity within each of these structures and excessive functional coupling among them. SCS disrupted this pathological circuit behavior in a manner that mimics the effects caused by pharmacological dopamine replacement therapy or deep brain stimulation. These results suggest that SCS should be considered as an additional treatment option for patients with PD.

[1]  Dr. Heinz Stephan,et al.  The Brain of the Common Marmoset (Callithrix jacchus) , 1980, Springer Berlin Heidelberg.

[2]  P. Petersson,et al.  Levodopa-Induced Dyskinesia Is Strongly Associated with Resonant Cortical Oscillations , 2012, The Journal of Neuroscience.

[3]  Michael Petrides,et al.  The marmoset brain in stereotaxic coordinates , 2012 .

[4]  A. Benabid,et al.  Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease. , 1987, Applied neurophysiology.

[5]  Juan Fernandez-Ruiz,et al.  Quantitative evaluation of MPTP-treated nonhuman parkinsonian primates in the HALLWAY task , 2009, Journal of Neuroscience Methods.

[6]  A. Smit,et al.  Two new test methods to quantify motor deficits in a marmoset model for Parkinson's disease , 2009, Behavioural Brain Research.

[7]  SPINAL CORD STIMULATION FAILED TO RELIEVE AKINESIA OR RESTORE LOCOMOTION IN PARKINSON DISEASE. AUTHORS' REPLY , 2010 .

[8]  Peter A. Tass,et al.  Desynchronizing electrical and sensory coordinated reset neuromodulation , 2012, Front. Hum. Neurosci..

[9]  Arnaud Delorme,et al.  EEGLAB: an open source toolbox for analysis of single-trial EEG dynamics including independent component analysis , 2004, Journal of Neuroscience Methods.

[10]  S. Fahn Unified Parkinson's Disease Rating Scale , 1987 .

[11]  T. Agari,et al.  Spinal cord stimulation for the treatment of abnormal posture and gait disorder in patients with Parkinson's disease. , 2012, Neurologia medico-chirurgica.

[12]  Stéphane Palfi,et al.  Spinal cord stimulation for chronic pain improved motor function in a patient with Parkinson's disease. , 2012, Parkinsonism & related disorders.

[13]  A. Bonnet,et al.  [The Unified Parkinson's Disease Rating Scale]. , 2000, Revue neurologique.

[14]  A. Oliviero,et al.  Dopamine-dependent changes in the functional connectivity between basal ganglia and cerebral cortex in humans. , 2002, Brain : a journal of neurology.

[15]  S B Dunnett,et al.  Behavioural analysis of unilateral monoamine depletion in the marmoset. , 1992, Brain : a journal of neurology.

[16]  A. Benabid,et al.  Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. , 2003, The New England journal of medicine.

[17]  S. Hassan,et al.  A patient with Parkinson’s disease benefits from spinal cord stimulation , 2013, Journal of Clinical Neuroscience.

[18]  A. Jha,et al.  SPINAL CORD STIMULATION FAILED TO RELIEVE AKINESIA OR RESTORE LOCOMOTION IN PARKINSON DISEASE , 2010, Neurology.

[19]  P. Jenner,et al.  Dopamine, but Not Norepinephrine or Serotonin, Reuptake Inhibition Reverses Motor Deficits in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Treated Primates , 2002, Journal of Pharmacology and Experimental Therapeutics.

[20]  J. Brotchie,et al.  Reversal of parkinsonian symptoms by intrastriatal and systemic manipulations of excitatory amino acid and dopamine transmission in the bilateral 6‐OHDA lesioned marmoset , 1995, Behavioural pharmacology.

[21]  Mei Zhang,et al.  Spinal Cord Stimulation Restores Locomotion in Animal Models of Parkinson ’ s Disease , 2009 .

[22]  R. Ridley,et al.  Sensorimotor deficits in a unilateral intrastriatal 6-OHDA partial lesion model of Parkinson’s disease in marmoset monkeys , 2003, Experimental Neurology.

[23]  信夫 武澤,et al.  Unified Parkinson's disease rating scale と三次元動作解析を用いたパーキンソン病患者のリハビリテーションの有効性の検討 , 2010 .

[24]  Partha P. Mitra,et al.  Automatic sorting of multiple unit neuronal signals in the presence of anisotropic and non-Gaussian variability , 1996, Journal of Neuroscience Methods.

[25]  M. Nicolelis,et al.  Spinal cord stimulation failed to relieve akinesia or restore locomotion in Parkinson disease , 2010, Neurology.

[26]  Jack W. Tsao,et al.  Observed brain dynamics, P.P. Mitra, H. Bokil. Oxford University Press (2008), ISBN-13: 978-0-19-517808-1, 381 pages, $65.00 , 2009 .

[27]  Partha Mitra,et al.  Short Course III Neural Signal Processing : Quantitative Analysis of Neural Activity , 2008 .

[28]  A. Antonini,et al.  Spinal Cord Stimulation for the Treatment of Sensory Symptoms in Advanced Parkinson's Disease , 2013, Neuromodulation : journal of the International Neuromodulation Society.

[29]  Izhar Bar-Gad,et al.  Beta oscillations in the cortico-basal ganglia loop during parkinsonism , 2013, Experimental Neurology.

[30]  R. Marconi,et al.  How many parkinsonian patients are suitable candidates for deep brain stimulation of subthalamic nucleus? Results of a questionnaire. , 2007, Parkinsonism & related disorders.

[31]  M. L. Nicolelis,et al.  Restoration of locomotive function in Parkinson’s disease by spinal cord stimulation: mechanistic approach , 2010, The European journal of neuroscience.

[32]  Grant D. Huang,et al.  Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. , 2010, The New England journal of medicine.

[33]  J. Eberling,et al.  Preclinical models of Parkinson's disease. , 2003, Current protocols in toxicology.